David M. DeMedio
Geen lopende functies
Loopbaan van David M. DeMedio
Eerdere bekende functies van David M. DeMedio
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CANTALOUPE, INC. | Financieel Directeur/CFO | 01-03-1999 | 31-08-2015 |
| Corporate Officer/Principal | 31-08-2015 | 14-10-2015 | |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Directeur/Bestuurslid | 01-10-2007 | 17-09-2008 |
Opleiding van David M. DeMedio
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Israël | 2 |
Operationeel
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoraal
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CANTALOUPE, INC. | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Beurs
- Insiders
- David M. DeMedio
- Ervaring
